Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 8,593-8,604 of 23,847
Drug study icon
CompletedNCT01192880

Bitopertin for schizophrenia

This study is completed in the United States, in Bulgaria, in China, .... It is testing bitopertin for schizophrenia.

Multiple locations, including Costa Mesa
SchizophreniaDrugOver 18 Years
Countries
United States, Bulgaria, China, ...
Sponsor
Hoffmann-La Roche
Condition
Schizophrenia
Drug study icon
CompletedNCT06796868

GW117 Tablets for depression

This study is completed in China. It is testing GW117 Tablets for depression.

Multiple locations, including Baoding
DepressionDrugFrom 18 Years to 65 Years
Countries
China
Sponsor
Beijing Greatway Pharmaceutical Technology Co.,Ltd.
Condition
Depression
Drug study icon
CompletedNCT02942004

SAGE-547 for depression

This study is completed in the United States. It is testing SAGE-547 for depression.

Multiple locations, including Chandler
DepressionDrugFrom 18 Years to 45 Years
Countries
United States
Sponsor
Supernus Pharmaceuticals, Inc.
Condition
Depression
Drug study icon
WithdrawnNCT05344365

Iloperidone for Schizophrenia

This study was withdrawn in the United States. It is testing iloperidone for Schizophrenia.

In St. Petersburg
SchizophreniaDrugOver 65 Years
Countries
United States
Sponsor
Vanda Pharmaceuticals
Condition
Schizophrenia
Drug study icon
CompletedNCT04712734

Iloperidone Long-acting Injection (LAI) for schizophrenia

This study is completed in the United States. It is testing Iloperidone Long-acting Injection (LAI) for schizophrenia.

Multiple locations, including Garden Grove
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Vanda Pharmaceuticals
Condition
Schizophrenia
Drug study icon
Active Not RecruitingNCT06817356

Mazdutide Compared With Placebo in people with Addiction

This study is active but not recruiting in the United States. It is testing mazdutide Compared With Placebo for Addiction.

Multiple locations, including Scottsdale
AddictionDrugFrom 21 Years to 65 Years
Countries
United States
Sponsor
Eli Lilly and Company
Condition
Addiction
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.